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Axonal injuries to motoneurons of adult mammals cause, among other responses, 
loss of synaptic terminals from their cell bodies and dendrites. This “synaptic 
stripping” is largely, but not always completely reversed after successful axonal 
regeneration and muscle reinnervation. Long-lasting deficits in, e.g., cholinergic and 
glutamatergic afferent terminals, correlate negatively with degree of functional 
recovery in rats suggesting that persistent partial deafferentation of motoneurons 
may be a factor limiting functional recovery after peripheral nerve injury.  
 
2.2 Aims 
To further explore the idea that functional recovery is partially linked to restoration of 
synaptic inputs to regenerated motoneurons, we pursued to modulate the 
deafferentation of motoneurons following nerve section/suture and monitor the 
effects of this manipulation on the outcome of peripheral nerve regeneration. Two 
neuroactive molecules, botulinum neurotoxin A (BoNT) and brain-derived 
neurotrophic factor (BDNF), known for their ability to influence synaptic inputs to 
neurons, were selected as manipulation tools. 
 
2.3 Material and methods 
Drug solutions were applied to the proximal stump of the freshly cut femoral nerve of 
rats to achieve drug uptake and transport to the neuronal perikarya and possibly 
transcytosis to afferent synapses. The experiments were performed in adult (10-
week-old) female Wistar rats which received either BoNT (N = 17), BDNF (N = 15) or 
bovine serum albumin treatment (BSA, control, N = 13). After drug application, the 
femoral nerve was surgically reconstructed and functional recovery was monitored 
over a 5-month period using an established gait analysis protocol. Other outcome 
measures were quality of endplate reinnervation (occurrence of abnormal 
polyinnervation assessed morphologically) and numbers of cholinergic, 
GABA/glycinergic and glutamatergic synaptic terminals in the femoral motor nucleus 




2.4 Results and discussion 
Application of BoNT, but not BDNF, resulted in a marked, as compared with BSA, 
improvement of motor recovery at 2 to 20 weeks after injury. At two months, BoNT-
treated rats had an attenuated loss of perisomatic cholinergic terminals compared 
with the other two treatments. Analysis of individual animal data revealed significant 
linear correlations between functional parameters and numbers of cholinergic 
terminals. Quality of endplate reinnervation was not affected by treatment with BoNT 
or BDNF. The effect of BoNT on synaptic terminals is possibly related to transcytosis 
of BoNT into perisomatic nerve terminals as suggested by immunohistochemical 
analysis of cleaved SNAP-25. In turn, better preservation of modulatory cholinergic 
terminals, which are crucial for normal motoneuron excitability, might underlie 
enhanced recovery of function in BoNT-treated rats.  
 
2.5 Conclusions 
The findings support the idea that persistent partial deafferentation of axotomized 
motoneurons is a factor contributing to deficient functional recovery after nerve injury. 
Intraneural application of drugs appears to be a promising way to analyze causal 
relationships between synaptic plasticity and restoration of function. In addition, it is 
thinkable that the described drug application approach may evolve into a clinically 
feasible therapy if further controlled animal experiments provide convincing evidence 




2.1  Hintergrund 
Läsionen peripherer Nerven von erwachsenen Säugetieren verursachen Verlust von 
Synapsen an Zellkörpern und Dendriten von Motoneuronen. Diese Deafferenzierung 
(“synaptic stripping“) ist, selbst nach erfolgreicher Nervenregeneration und 
Reinnervation der Muskulatur, nicht immer vollkommen reversibel. Langfristige 
Defizite sind für cholinerge und glutamaterge Afferenzen nachgewiesen und diese 
korrelieren negativ mit dem Grad der funktionellen Erholung bei Ratten. Es kann 
angenommen werden, dass eine persistierende partielle Deafferenzierung von 




Um die o. g. Hypothese zu überprüfen, wurde hier versucht die Deafferenzierung der 
Motoneurone nach Durchtrennung und Naht des Nervus femoralis der Ratte zu 
manipulieren. Zwei neuroaktive Moleküle, Botulinum-Neurotoxin A (BoNT) und Brain-
derived neurotrophic factor (BDNF), die bekanntlich synaptische Eingänge an 
Neuronen beeinflussen, wurden als „Manipulationswerkzeuge“ ausgewählt. Die 
Effekte dieser Behandlungen auf das Outcome der Nervenregeneration wurden 
funktionell und strukturell untersucht.  
 
2.3 Material und Methoden 
BoNT oder BDNF wurden an den proximalen Stumpf des durchtrennten Nervus 
femoralis appliziert, um ihre Aufnahme und den Transport zu den Perikarya sowie 
eventuell die Transzytose zu afferenten Synapsen zu erreichen. Als Kontrolle diente 
bovines Serumalbumin (BSA). Die Experimente wurden an erwachsenen, zehn 
Wochen alten weiblichen Wistar Ratten durchgeführt, die entweder eine BoNT (N = 
17), BDNF (N = 15) oder BSA (N = 13) Behandlung erhielten. Nach der Applikation 
wurde der Nerv chirurgisch rekonstruiert und die funktionelle Erholung mithilfe eines 
etablierten Ganganalyseverfahrens in einem Zeitraum von fünf Monaten 
dokumentiert. Weitere Outcome-Parameter waren die Qualität der 
Endplattenreinnervation (Auftreten anormaler Polyinnervation) und die Anzahl der 
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cholinergen, GABA/glycinergen und glutamatergen synaptischen Terminale im 
motorischen Kern des N. femoralis im Rückenmark. 
 
2.4 Ergebnisse und Diskussion 
Zwei bis 20 Wochen nach der Läsion war die funktionelle Erholung nach BoNT 
Applikation signifikant besser im Vergleich zu den anderen beiden Behandlungen. 
Der posttraumatische Verlust an perisomatischen cholinergen Synapsen zwei 
Monate nach der Operation war ebenso reduziert in BoNT-behandelten Tieren. 
Regressionsanalysen zeigten signifikante lineare Korrelationen zwischen 
Funktionsparametern und der Anzahl cholinerger Terminale. Die Qualität der 
Endplattenreinnervation wurde nicht durch die Behandlung mit BoNT oder BDNF 
beeinflusst. Die Effekte von BoNT beruhen, wie durch Nachweis von gespaltetem 
SNAP-25 in perisomatischen Nerventerminale angedeutet, möglicherweise auf BoNT 
Transzytose. Eine bessere Erhaltung der modulatorischen cholinergen Terminale, die 
für die normale Erregbarkeit von Motoneuronen von entscheidender Bedeutung sind, 
könnte wiederum einer verbesserten Erholung der Funktion bei mit BoNT 
behandelten Ratten zugrunde liegen. 
 
2.5 Schlussfolgerungen 
Die Ergebnisse stützen die Hypothese, dass langanhaltende partielle 
Deafferenzierungen von Motoneuronen negative Auswirkungen auf die funktionelle 
Erholung nach Nervenläsionen haben können. Die intraneurale Anwendung von 
neuroaktiven Substanzen scheint ein vielversprechender Weg zu sein, um kausale 
Zusammenhänge zwischen synaptischer Plastizität und Wiederherstellung der 
Funktion zu analysieren. Es ist außerdem denkbar, dass sich der beschriebene 
Ansatz der Arzneimittelapplikation zu einer klinisch durchführbaren Therapie 
entwickeln kann, wenn weitere kontrollierte Tierversuche überzeugende Beweise für 





3.1 Synaptic stripping 
Peripheral axotomy in adult laboratory animals and humans causes loss of synaptic 
terminals from cell bodies and dendrites, a phenomenon known as synaptic stripping 
(Blinzinger and Kreutzberg, 1968; Graeber et al., 1993). The synaptic terminal 
displacement is mediated by activated microglia and supported by astrocytes that 
isolate the postsynaptic elements by thin lamellae (Blinzinger and Kreutzberg, 1968; 
Kerns and Hinsman, 1973a,b; Sumner and Sutherland, 1973; Chen, 1978; 
Kreutzberg, 1993; Borke et al., 1995). In general, it is considered that the 
posttraumatic loss of synapses is a temporary phenomenon which is completely 
reversed as reinnervation proceeds and muscles become reinnervated (Sumner and 
Sutherland, 1973; Sumner, 1975; Chen, 1978). However, a few publications have 
reported that restoration of particular synaptic inputs is incomplete, namely of 
inhibitory F-type (containing flat vesicles) terminals  on reinnervated cat medial 
gastrocnemius motoneurons (Brännström and Kellerth, 1999) and proprioceptive Ia 
afferent synapses (VGLUT1-immunoreactive boutons) on rat tibialis motoneurons 
(Rotterman et al., 2014; Schultz et al., 2017).  
 Physiologically, the acute post-traumatic deafferentation is believed to be a 
response protecting the axotomized, and thus transmission disabled motoneurons 
against excitotoxicity (Spejo and Oliveira, 2015). The functional consequences of 
reafferentation deficits after muscle reinnervation have received little attention. One 
exception is the hypothesis that permanent loss of Ia afferent synapses and failure to 
restore the stretch reflex essentially contribute to poor functional recovery after spinal 
nerve injury and repair (Rotterman et al., 2014; Schultz et al., 2017). 
 
3.2 Synapses as variables relevant for functional recovery 
Recent studies in our laboratory have suggested that functional limitations after 
successful muscle reinnervation may in part be attributed to deficient reafferentation 
of motoneurons (Hundeshagen et al., 2013; Raslan et al., 2014). Using the facial 
nerve model and nerve lesions of different severity (“mild” cryolesion and “severe” 
section/suture), the studies revealed that degree of functional recovery, estimated by 
quantitative whisker motion analysis, is positively correlated, on an individual basis, 
with numbers of persisting cholinergic and glutamatergic terminals in the motor 
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nucleus following long-term reinnervation. The suggested structure-function 
relationships are plausible since glutamatergic and cholinergic synapses determine 
drive and excitability of motoneurons, respectively (Miles et al., 2007; Heckman et al., 
2009; Raslan et al., 2014).   
 
3.3 Modulation of motoneuron innervation 
The next logical step on the way to prove a causal relationship between synaptic 
numbers and functional outcome was to manipulate the independent variable, 
synapses, and monitor changes in behavior. In this study we pursued to influence 
synaptic responses after peripheral nerve injury by using BoNT and BDNF. The 
reasons for this choice were as follows: 
 
3.3.1 BoNT 
Upon intramuscular application, BoNT blocks synaptic transmission at the 
neuromuscular junction and, in addition, is transported retrogradely to the 
motoneuron cell body and possibly also transcytosed to afferent synaptic terminals 
(Antonucci et al., 2008; Matak et al., 2012; Restani et al., 2012a,b). BoNT causes 
progressive synaptic stripping detectable at 4 days after intramuscular injection and 
abolishes excitatory and inhibitory synaptic transmission on motoneurons at 1-2 
weeks after application (Pastor et al., 1997). Rather than intramuscularly, we applied 
the drug to the proximal nerve stump immediately after nerve transection similar to 
the application of retrograde tracers. The rationale behind this unusual type of 
application was three-fold: 1/ to avoid possible involvement of the periphery (muscle), 
which could blur the results, 2/ to eventually achieve high (though not measurable!) 
drug concentrations in the cell body and 3/ create a model relevant for potential 
clinical application (possibility to apply drug only to the severed nerve prior to surgical 
reconstruction in humans). The expectation was that BoNT will significantly enhance 
synaptic stripping.  
 
3.3.2 BDNF 
With an intraneural application similar to BoNT, we expected to achieve opposite 
effects using BDNF, i.e. attenuation of synaptic loss. When administered to the 
proximal axons immediately after transection, BNDF reduces synaptic stripping and 
enhances recovery of tonic firing of regenerating motoneurons (Davis-Lopez de 
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Carrizosa et al., 2009). Synaptotrophic effects of exogenous BDNF have also been 
reported after ventral root avulsion (Novikov et al., 2000). Finally, a single session of 
brief electrical stimulation (20 Hz, 1 hour) of the proximal stump of the freshly 
transected femoral nerve in rats leads to enhanced nerve regeneration over weeks 
and this effect is apparently associated with an up-regulation of BDNF and its 
cognitive receptor trkB in the motoneuron cell body (Al-Majed et al., 2000a,b). It is 
plausible that enhanced BDNF signaling is beneficial for regeneration via 
synaptotrophic effects.  
 
3.4 The experimental model 
The femoral nerve model in rats was selected for this first experiment using 
intraneural drug application. The anatomy in this model allows work with a longer 
proximal trunk after nerve transection as compared with, for example, the facial nerve 
and, thus, easier and more secure drug application using plastic mini-cups. The well-
established femoral nerve model in rodents is a valuable alternative to other spinal 
nerve models like the sciatic one offering the possibility to analyze precision of target 
reinnervation, reliable functional assessments and a straightforward search of 
anatomical deficits and structure-function correlations (Irintchev, 2011). A very helpful 
background was also the existence of extensive data on long-term functional 
recovery, precision of motor reinnervation and correlations between these measures 
after suture/section of the femoral nerve in adult rats (Kruspe et al., 2014). The 
outcome measures used in this study included: 1/ motor recovery test (single-frame 
motion analysis, SFMA), 2/ stereological estimates of chemically defined nerve 
terminal densities in the femoral motor nucleus and 3/ retrograde labeling of 
motoneurons. Whenever possible and meaningful, both functional and structural 







This work was designed to test the hypothesis that exogenous drugs can modulate 
injury-induced synaptic rearrangements in the femoral motor nucleus of adult rats 
and, as a consequence, alter the functional outcome. 
 A first step towards a successful experimental solution was to test if synaptic 
stripping can be modulated using the selected model, type of drug application and 
drug concentrations. The results of this experiment (Experiment I in 5.), in which I 
was not directly involved, showed that one week after injury and drug application 
BoNT leads to a reduced loss of GABA/glycinergic terminals and both BoNT and 
BDNF increase the numbers of remaining cholinergic perisomatic synaptic terminals 
(data in Fig. 3 in 5.). These results clearly showed the feasibility of the project and 
warranted further progression of the work focused on the following specific aims: 
 1. To test the long-term (at 2 months post-lesion) functional effects after 
femoral nerve transection, application of BoNT, BDNF or BSA (control) to the 
proximal nerve trunk and subsequent nerve reconstruction (Experiment II in 5.). The 
method of choice here was single-frame motion analysis (SFMA), an established 
approach for functional analyses after spinal nerve lesions. 
2. To test, in the same animal groups, the long-term effects of the drugs on 
numbers of inhibitory (GABA/glycinergic), excitatory (glutamatergic) and modulatory 
(cholinergic) terminals and microglia in the femoral motor nucleus of the spinal cord. 
The method of choice here was stereological assessment of synaptic terminal and 
cell densities using the optical disector method, a routinely used approach in our 
laboratory. 
3. To analyze the long-term functional effects (over 5 months) of BoNT, BDNF 
and BSA application using the SFMA approach (Experiment III in 5.).  
4. To analyze the precision of motor reinnervation in the animal groups 
mentioned above (point 3.) using retrograde labeling of correctly and incorrectly 
regenerated motoneurons, i.e., via the femoral and saphenous nerve branch, 
respectively. The back-labeling method is a routine technique in the laboratory. 


































The results of this study strongly support the hypothesis that the degree of 
preservation/recovery of synaptic inputs to regenerated motoneurons, in particular 
cholinergic perisomatic terminals, influences functional recovery after peripheral 
nerve injury. In addition, the work demonstrates, for the first time, that drug 
application to the acutely severed peripheral nerve is a feasible approach to 
manipulate post-lesion synaptic plasticity and functional recovery.  
 
6.1 Methodological considerations 
The femoral nerve model in mice and rats has been widely used for regeneration 
studies (Irintchev, 2011). It has been initially employed as a model system to study 
specificity of motor reinnervation in a choice situation (mixed quadriceps versus 
purely sensory saphenous nerve branch) using retrograde tracing methods (Brushart, 
1988, 1993). Substantial enrichment of the model was the design of an objective 
numerical test for assessment of quadriceps motor function, the single frame motion 
analysis (SFMA, Irintchev et al., 2005b). The combination of SFMA and 
morphological methods like retrograde tracing, axonal morphometry and synaptic 
terminal counts gives the opportunity to search for variables determining the outcome 
of nerve regeneration (Eberhardt et al., 2006; Ahlborn et al., 2007; Mehanna et al., 
2010; Guseva et al., 2009, 2011, 2018) . The SFMA method is validated for rats and 
characterized by high precision, reliability and reproducibility (Kruspe et al., 2014). 
The SFMA results in this experiment are in full agreement with previous data on the 
course and outcome of femoral nerve section/suture (Kruspe et al., 2014). The 
analyses were performed in a blind fashion and the coefficients of variation (standard 
deviation / mean group value, a measure of precision and repeatability of an assay) 
for individual data sets (animal group on particular postoperative day) were typically 
as low as 2% - 7%. Therefore, it can be assumed that the results on functional 
recovery in this study are reliable.   
 Another technique of major importance for this experimental study was the 
stereological assessment of cell and synaptic terminal densities. This approach, in 
particular the optical disector method, also has a long tradition in our laboratory and 
has been successfully applied in studies on different CNS areas of rodents (Irintchev 
et al., 2005a; Nikonenko et al., 2006; Jakovcevski et al., 2009; Tereshchenko et al., 
2011; Hundeshagen et al., 2013; Raslan et al., 2014). The optical disector enables 
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precise (“unbiased”) estimates of object densities based on systematic random 
sampling of sections with a three-dimensional probe (Howard and Reed, 1998). 
Using standardized immunohistochemical protocols on spaced serial sections and 
optical disector, densities of different structures, e.g. different types of cells or 
synaptic terminals, can be estimated in the same reference volume and are, thus, 
comparable to each other (Irintchev et al., 2005a; Raslan et al., 2014). Blinded 
analyses, rigorous application of stereological principles and high-quality 
immunofluorescence stainings were the prerequisites for generating reliable 
numerical data in our present experiments. At the same time it has to be underlined 
that we estimated densities of synaptic terminals, i.e. presynaptic elements, and this 
is not automatically equivalent to densities of synapses consisting of pre- and 
postsynaptic elements. This means that, for example, the number of terminals 
“detached”, i.e. separated by thin astrocytic lamellae, from their post-synaptic 
counterparts during post-traumatic synaptic elimination, cannot be identified and 
counted separately from “attached” terminals, i.e. synapse-forming ones. Electron 
microscopy alone or in combination with immunohistochemistry provides the 
opportunity to identify synapses of defined type. However, this procedure is 
extremely labor intensive and the sample sizes that can be achieved, often limited to 
a few synapses in an animal group, might not be representative (Brannstrom and 
Kellerth, 1998; Brännström and Kellerth, 1999). Therefore, analyses of synaptic 
terminals and not synapses are currently standard procedures in many laboratories 
(Davis-Lopez de Carrizosa et al., 2010; Berg et al., 2012; Mehanna et al., 2014; 
Chawla et al., 2017; Schultz et al., 2017). 
 
6.2 Drug effects on synaptic terminal numbers 
Prior to the experiments it was hypothesized that BDNF would have synaptotrophic 
effects and, indeed, the results showed that injury-related loss of ChAT+ perisomatic 
boutons is prevented at 1 week. At 2 months after injury, however, the effect was no 
longer present. Also excitatory VGLUT2+ and inhibitory VGAT+ terminals were 
affected at neither 1 week nor 2 months, and VGLUT1+ terminals were even reduced 
at 2 months after injury (Table 2 in 5.). It is possible that the intracellular 
concentration of active exogenous BDNF achieved in our experiment has not been 
optimal to produce pronounced, long-term effects. BDNF appears to have a dose-
dependent influence on nerve regeneration, i.e. facilitation at low doses and inhibition 
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at higher ones (Richner et al., 2014). Therefore, future dose-dependence studies are 
required to properly assess the value of BDNF as a regeneration promoting agent in 
our model.  
In contrast to BDNF, BoNT was expected to enhance loss of terminals after 
axotomy with a more pronounced effect on excitatory (VGLUT1+ and VGLUT2+) than 
on inhibitory (VGAT+) terminals (Verderio et al., 2004, 2007). Such effects were not 
found at 2 months after injury. Surprisingly, the only significant, long-lasting effect, on 
ChAT+ terminals, was synaptotrophic (Table 2 in 5.). Such an effect cannot be 
explained by the known major mechanism of BoNT action – inhibition of synaptic 
transmission via cleaving of SNAP-25 (Verderio et al., 2004). A possible mechanism 
underlying this effect is partial inhibition and reactive sprouting of the cholinergic input 
to motoneurons. BoNT neurotrophic effects could possibly be also achieved via co-
localization and signaling through the p75 receptor (Restani et al., 2012a; Cobianchi 
et al., 2017). Only future experiments can reveal the true mechanism(s) underlying 
the unexpected synaptotrophic action of BoNT. 
 
6.3 Mechanisms underlying enhanced functional recovery 
We applied BoNT only once using the time frame between axonal membrane 
damage and sealing to load the proximal axon and cell body with toxin similar to 
retrograde tracers. Our expectation was that this uptake will be sufficient to “prime” 
the initial responses of motoneurons to injury, in particular their deafferentation, and, 
thus, eventually achieve long-term effects on regeneration without need of repeated 
drug delivery to the injury site. As estimated by gait analysis, our experiment was 
successful since functional regeneration was enhanced already at two weeks after 
injury and recovery remained accelerated for months thereafter. Enhancement of 
axonal regrowth in the crushed sciatic nerve of mice by a single low-dose intraneural 
application of BoNT has been just reported but the underlying mechanism(s) for 
these effects have remained unclear (Cobianchi et al., 2017). Here we propose that 
the improvement of regeneration in our model is a consequence of attenuated loss of 
cholinergic modulatory input to femoral motoneurons (see 6.4). In addition, it is 
possible that BoNT has an additional neuroprotective effect. At one week after injury 
we found, compared with control rats, an increase in VGAT+ inhibitory afferents in the 
quadriceps motor nucleus, reduced numbers of excitatory VGLUT1+ Ia afferents and 
no change in excitatory VGLUT2+ terminals (Table 2 in 5.). We can speculate that 
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this constellation attenuates the increased excitability of the axotomized motoneurons 
and, thus, allows better recovery of the motoneuron and its better regeneration 
(Davis-Lopez de Carrizosa et al., 2009; Gonzalez-Forero and Moreno-Lopez, 2014). 
It is also thinkable that BoNT-related modulations of reflexes and/or pain-related 
transmission may have also positive functional consequences (Kerzoncuf et al., 
2015; Mazzocchio and Caleo, 2015; Kumar et al., 2016; Sandrini et al., 2017).  
  
6.4 Perisomatic C-type cholinergic synapses 
This work linked better functional recovery with higher numbers of cholinergic 
perisomatic terminals in BoNT-treated animals. The correlations between ChAT+ 
terminal numbers and functional parameters were strong (r2 ~ 0.70), in contrast to 
other variables studied, other types of synapses and preferential motor reinnervation. 
In addition, previous work using facial nerve or spinal cord injury models has also 
shown strong statistical relationships between degree of functional recovery, on one 
side, and degree of preservation/recovery of ChAT+ terminal frequency on facial 
(Hundeshagen et al., 2013; Raslan et al., 2014) or spinal motoneurons (Apostolova 
et al., 2006; Jakovcevski et al., 2007; Lee et al., 2009), on the other side. These large 
cholinergic terminals form C-type synapses on motoneuronal perikarya and proximal 
dendrites and utilize M2 muscarinic receptors for acetylcholine in the postsynaptic 
membrane (Davidoff and Irintchev, 1986; Nagy et al., 1993; Hellstrom et al., 1999; 
Hellström et al., 2003; Wilson et al., 2004; Csaba et al., 2013). Although not that 
numerous, these synapses strongly influence motoneuron  function by regulating 
action potential afterhyperpolarization in a way that, under normal conditions, 
ensures sufficient motoneuron output to drive motor behavior (Miles et al., 2007; 
Zagoraiou et al., 2009). It can be, therefore, assumed that partial loss of perisomatic 
cholinergic terminals, associated with a reduced expression of postsynaptic receptors 
(Hoover and Hancock, 1985; Hoover et al., 1996), may significantly impair motor 





7. Conclusions and perspectives 
The results of this study suggest that preservation of the C-terminal input to 
motoneurons favors functional recovery after nerve injury and regeneration. It is 
encouraging that a single intraoperative drug application can lead to long lasting 
positive functional effects. Many different agents could also be useful tools to modify 
neuronal responses to axotomy and improve functional outcome: neurotrophin-3 
(Davis-Lopez de Carrizosa et al., 2009), NGF (Davis-Lopez de Carrizosa et al., 
2010), vascular endothelial growth factor, VEGF (Calvo et al., 2018) or small 
bioactive molecules (Lo et al., 2014). Although BoNT is widely used in contemporary 
medicine, further experimental research is required before it can be considered as a 
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